Omacor and Oesophagitis ulcerative - a phase IV clinical study of FDA data

Summary:

Oesophagitis ulcerative is reported as a side effect among people who take Omacor (omega-3acid ethyl esters), especially for people who are male, 60+ old, also take Ibuprofen, and have Heart disease.

The phase IV clinical study analyzes which people have Oesophagitis ulcerative when taking Omacor. It is created by eHealthMe based on reports of 2,506 people who have side effects when taking Omacor from the FDA, and is updated regularly.

What is Omacor?

Omacor has active ingredients of omega-3acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 2,547 Omacor users. Check the latest studies of Omacor.

What is Oesophagitis ulcerative?

Oesophagitis ulcerative (inflammation of oesophagus with multiple ulcers) is found to be associated with 228 drugs and 297 conditions by eHealthMe. Check the latest studies of Oesophagitis ulcerative.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

2,506 people reported to have side effects when taking Omacor.
Among them, 19 people (0.76%) have Oesophagitis ulcerative.

Could Omacor cause Oesophagitis ulcerative?

Among these 19 people:

What is the gender of people who have Oesophagitis ulcerative when taking Omacor? *

female: 0.0 %
male: 100 %

What is the age of people who have Oesophagitis ulcerative when taking Omacor? *

What are other drugs people take besides Omacor? *

What are other side effects people have besides Oesophagitis ulcerative? *

Thrombocytopenia (decrease of platelets in blood): 18 people, 94.74%
Haematemesis (vomiting of blood): 18 people, 94.74%
Duodenitis (inflammation of the duodenum): 18 people, 94.74%
Gastritis (inflammation of stomach): 18 people, 94.74%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 17 people, 89.47%
Confusional State: 13 people, 68.42%
Blood Urea Increased: 10 people, 52.63%
Blood Creatinine Increased: 6 people, 31.58%
Blood Creatine Increased: 4 people, 21.05%
Oesophageal Stenosis (narrowing of oesophagus): 1 person, 5.26%

What are the existing conditions these people have? *

Heart Disease: 18 people, 94.74%
Type 2 Diabetes: 1 person, 5.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Omacor and have Oesophagitis ulcerative?

- Check whether Oesophagitis ulcerative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omacor:

Omacor (2,547 reports)

Browse all side effects of Omacor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oesophagitis ulcerative:

Oesophagitis ulcerative (228 drugs)

Browse all the conditions that are associated with Oesophagitis ulcerative:

Oesophagitis ulcerative (297 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omega-3acid ethyl esters (the active ingredients of Omacor) and Omacor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.